Avalo Therapeutics, Inc.
AVTX · XNASCIK 1534120fmd_15BSEZ369CF07MVZW79XPD481SManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods
Loading
Latest annual · FY2025
Millions- Total revenues
- 0
- Gross profit
- 1
- Operating income
- (73)
- Net income
- (78)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -85.2%
- Revenue, 5 yearsFY2020 to FY2025
- -61.2%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Avalo Therapeutics, Inc. (AVTX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $59,000 | $441,000 | -86.6% | 10-K 2026-03-23 · proof |
| Operating income | -$72.9 million | -$68.5 million | 10-K 2026-03-23 · proof | |
| Net income | -$78.3 million | -$35.1 million | 10-K 2026-03-23 · proof |
- What was Avalo Therapeutics, Inc. (AVTX)'s revenue in fiscal 2025?
- Avalo Therapeutics, Inc. (AVTX) reported revenue of $59,000 for fiscal 2025 (the year ended Dec 31, 2025), against $441,000 the year before (-86.6%). Source: the 10-K filed with the SEC on Mar 23, 2026. SEC
- What was Avalo Therapeutics, Inc. (AVTX)'s operating income in fiscal 2025?
- Avalo Therapeutics, Inc. (AVTX) reported operating income of -$72.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$68.5 million the year before. Source: the 10-K filed with the SEC on Mar 23, 2026. SEC
- What was Avalo Therapeutics, Inc. (AVTX)'s net income in fiscal 2025?
- Avalo Therapeutics, Inc. (AVTX) reported net income of -$78.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$35.1 million the year before. Source: the 10-K filed with the SEC on Mar 23, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:AVTX&period_type=annual&limit=5"Information only, not investment advice.